Gleason Group’s GoHealth GOCO Stock Holding History

Gleason Group’s Portfolio GOCO Stock Details GOCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-167	Closed	-$29K	–	199
2021 Q1	$29K	Hold	167	–	–	0.01%	120
2020 Q4	$34K	Hold	167	–	–	0.02%	109
2020 Q3	$33K	Buy	+167	New	+$40.2K	0.02%	106

Other funds holding GOCO

Centerbridge Partners New York $38.1M AUM 9.24% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

RRAM

River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $128B AUM 35.83% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Gleason Group's GOCO Position: Q2 2021 in Review

Gleason Group sold out of GoHealth (GOCO) in Q2 2021, closing a stake of 167 shares — an estimated $29K sold.

Gleason Group first reported a position in GOCO in Q3 2020 and held it in 3 quarters. The position peaked at $34K in Q4 2020. 106 funds tracked by Wall St. Rank hold GOCO as of Q2 2021.

Gleason Group reported no remaining GoHealth position as of Q2 2021 after selling out during the quarter.
Gleason Group sold 167 GoHealth shares in Q2 2021, an estimated $29K.
Gleason Group first reported a position in GoHealth in Q3 2020 and held it in 3 quarters.
Gleason Group's GoHealth position peaked at $34K in Q4 2020.
106 funds tracked by Wall St. Rank held GoHealth as of Q2 2021.

Based on Gleason Group's 13F filing for Q2 2021, filed 27 Jul 2021.